External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Neuroscience EAN 2025
Roche and Genentech at

EAN 2025

June 21 - June 24
Helsinki, Finland / Virtual (Hybrid)
ean.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
11:10 AM
Duration 5mins Room B1
Placental and Breastmilk Transfer of Ocrelizumab From Women With Multiple Sclerosis to Infants: MINORE and SOPRANINO
Bove, Riley; Oreja-Guevara, Celia; Vukusic, Sandra; Shah, Anna; Graham, Edith L.; McElrath, Thomas; Pietrasanta, Carlo; Dobson, Ruth; Maillart, Elisabeth; Jacobs, Dina; Kletzl, Heidemarie; Kazlauskaite, Agne; Alves, Daniela; Raposo, Catarina; Craveiro, Licinio; Lin, Chien-Ju; Pasquarelli, Noemi; Hellwig, Kerstin
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
11:20 AM
Duration 5mins Room B1
Peripartum Disease Activity in Women With Multiple Sclerosis: Ocrelizumab Clinical Trials and a Noninterventional Study
Buttmann, Mathias; Ziemssen, Tjalf; Bove, Riley; Hellwig, Kerstin; Gondos, Adam; Siadimas, Thanos; Walter, Saskia; Lin, Chien-Ju; Pasquarelli, Noemi; Vukusic, Sandra
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
11:25 AM
Duration 5mins Room B1
Ocrelizumab Treatment in Multiple Sclerosis: 11-year Efficacy and Safety Clinical Trial Data
Buttmann, Mathias; Montalban, Xavier; Giovannoni, Gavin; Filippi, Massimo; Schneble, Hans-Martin; Craveiro, Licinio; Pasquarelli, Noemi; Chognot, Cathy; Wang, Qing; Derfuss, Tobias
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
11:05 AM
Duration 5mins Room B1
Ocrelizumab Subcutaneous Administration: Further Characterization of the Benefit–Risk Profile From the OCARINA II Study and Patient Preferences
Centonze, Diego; Goldstick, Lawrence; Selmaj, Krzysztof; Krzystanek, Eva; Zecevic, Dusanka; Figueiredo, Catarina; Clinch, Susanne; Giacobino, Caroline; Azmi, Jay; Newsome, Scott D
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.